Details for New Drug Application (NDA): 213885
✉ Email this page to a colleague
The generic ingredient in LENALIDOMIDE is lenalidomide. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the lenalidomide profile page.
Summary for 213885
Tradename: | LENALIDOMIDE |
Applicant: | Eugia Pharma |
Ingredient: | lenalidomide |
Patents: | 0 |
Suppliers and Packaging for NDA: 213885
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 213885 | ANDA | Aurobindo Pharma Limited | 59651-342 | 59651-342-01 | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 213885 | ANDA | Aurobindo Pharma Limited | 59651-342 | 59651-342-07 | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 2.5MG | ||||
Approval Date: | Mar 6, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
Approval Date: | Mar 6, 2023 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | Mar 6, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription